Overweight and Obesity
Metabolic·MeSH: Obesity
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
1 drug in development·1 company·17 clinical trials
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| WVE-007 | Wave Life Sciences Ltd. (WVE) |
Frequently asked questions
How many drugs are in development for Overweight and Obesity?
BioSniper tracks 1 drug in development for Overweight and Obesity across 1 company.
How many clinical trials target Overweight and Obesity?
There are 17 clinical trials targeting Overweight and Obesity tracked by BioSniper.
What is the prevalence of Overweight and Obesity?
The estimated prevalence of Overweight and Obesity is approximately 42000.0 per 100,000 population.
Deep-dive into Overweight and Obesity
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis